Jéseka Gabriela Schirmann

Jéseka Gabriela Schirmann

Auto-generated profile, based on publicly available information

Jéseka Gabriela Schirmann

Laboratory of Research of Bioactive Molecules, Department of Chemistry, State University of Londrina, Londrina, PR, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2019 in Annals of Microbiology
Verified
Journal Article
Open access
PDF file
GYGeorge M. Yada
George M. Yada
ISIgor S. Shiraishi
Igor S. Shiraishi
RDRobert F. H. Dekker
Robert F. H. Dekker
JSJéseka G. Schirmann
Jéseka G. Schirmann
ABAneli M. Barbosa-Dekker
Aneli M. Barbosa-Dekker
JDJuliana Daniel
Juliana Daniel
Purpose: Flubendiamide is a highly toxic and persistent insecticide that causes loss of insect muscle functions leading to paralysis and death. The objective was to screen for filamentous fungi in soils where insecticides had been applied, to isolate entomopathogenic fungi from insect larva (Anticarsia gemmatalis) that infest soybean crops, and to use these in biodegradation of insecticides. Method: Filamentous fungi were isolated from soils, and growth inhibition was evaluated on solid medium containing commercial insecticides, Belt® (flubendiamide) and Actara® (thiamethoxam). A total of 133 fungi were isolated from soil and 80 entomopathogenic fungi from insect larva. Based on growth inhibition tests, ten soil fungi, 2 entomopathogenic fungi, and Botryosphaeria rhodina MAMB-05 (reference standard) were selected for growth on commercial insecticides in solid media. Fungi were grown in submerged fermentation on media containing commercial insecticides and assayed for laccase activity. Result: Isolates JUSOLCL039 (soil), JUANT070 (insect), and MAMB-05 performed best, and were respectively inhibited by 48.41%, 75.97%, and 79.23% when cultivated on 35 g/L Actara®, and 0.0, 5.42%, and 43.39% on 39.04 g/L Belt®. JUSOLCL039 and JUANT070 were molecularly identified as Trichoderma koningiopsis and Neurospora sp., respectively. The three fungal isolates produced laccase constitutively, albeit at low activities. Fungal growth on pure flubendiamide and thiamethoxam resulted in only thiamethoxam inducing high laccase titers (10.16 U/mL) by JUANT070. Neurospora sp. and B. rhodina degraded flubendiamide by 27.4% and 9.5% in vivo, while a crude laccase from B. rhodina degraded flubendiamide by 20.2% in vitro. Conclusion: This is the first report of fungi capable of degrading flubendiamide, which have applications in bioremediation.

1 August 2020 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
VCVirginia Marcia Concato
Virginia Marcia Concato
FTFernanda Tomiotto-Pellissier
Fernanda Tomiotto-Pellissier
TSTaylon Felipe Silva
Taylon Felipe Silva
MGManoela Daiele Gonçalves
Manoela Daiele Gonçalves
BBBruna Taciane da Silva Bortoleti
Bruna Taciane da Silva Bortoleti
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli

28 April 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJéseka G. Schirmann
Jéseka G. Schirmann
BBBruna Taciane da Silva Bortoleti
Bruna Taciane da Silva Bortoleti
MGManoela D. Gonçalves
Manoela D. Gonçalves
FTFernanda Tomiotto-Pellissier
Fernanda Tomiotto-Pellissier
PCPriscila Goes Camargo
Priscila Goes Camargo
ABAneli M. Barbosa-Dekker
Aneli M. Barbosa-Dekker
Available treatments for leishmaniasis have been widely used since the 1940s but come at a high cost, variable efficacy, high toxicity, and adverse side-effects. 3,3′,5,5′-Tetramethoxy-biphenyl-4,4′-diol (TMBP) was synthesized through laccase-catalysis of 2,6-dimethoxyphenol and displayed antioxidant and anticancer activity, and is considered a potential drug candidate. Thus, this study aimed to evaluate the anti-leishmanial effect of TMBP against promastigote and amastigote forms of Leishmania (L.) amazonensis and investigated the mechanisms involved in parasite death. TMBP treatment inhibited the proliferation (IC50 0.62–0.86 µM) and induced the death of promastigote forms by generating reactive oxygen species and mitochondrial dysfunction. In intracellular amastigotes, TMBP reduced the percentage of infected macrophages, being 62.7 times more selective to the parasite (CC50 53.93 µM). TMBP did not hemolyze sheep erythrocytes; indicative of low cytotoxicity. Additionally, molecular docking analysis on two enzyme targets of L. amazonensis: trypanothione reductase (TR) and leishmanolysin (Gp63), suggested that the hydroxyl group could be a pharmacophoric group due to its binding affinity by hydrogen bonds with residues at the active site of both enzymes. TMBP was more selective to the Gp63 target than TR. This is the first report that TMBP is a promising compound to act as an anti-leishmanial agent.

11 February 2022 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
GMGabriel J. Mattos
Gabriel J. Mattos
JSJéseka G. Schirmann
Jéseka G. Schirmann
CSCarlos A. R. Salamanca-Neto
Carlos A. R. Salamanca-Neto
RDRobert F. H. Dekker
Robert F. H. Dekker
ABAneli M. Barbosa-Dekker
Aneli M. Barbosa-Dekker
ESElen R. Sartori
Elen R. Sartori

24 April 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
FIFabricio Seidy Ribeiro Inoue
Fabricio Seidy Ribeiro Inoue
VCVirginia Marcia Concato-Lopes
Virginia Marcia Concato-Lopes
BBBruna Taciane da Silva Bortoleti
Bruna Taciane da Silva Bortoleti
ECEllen Mayara Souza Cruz
Ellen Mayara Souza Cruz
MDMariana Barbosa Detoni
Mariana Barbosa Detoni
WPWander Rogério Pavanelli
Wander Rogério Pavanelli
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with frequent recurrence and chemoresistance, underscoring the need for new treatment strategies. 3,3',5,5'-Tetramethoxybiphenyl-4,4'-diol (TMBP) showed cytotoxicity against lung cancer cell lines without harming normal cells. Thus, we investigated the antitumoral effect of TMBP on HCC cell lines, HuH7.5 (p53-mutant) and HepG2/C3A (p53-wild type). Cells were treated with TMBP (12.5-150 µM) for 24 and 48 h, and metabolic cellular activity (MTT) were used to determine the 50 % inhibitory concentration (IC50) values. TMBP cytotoxicity were assessed by Trypan blue assay, scanning and transmission electron microscopy. Cell migration (wound healing), total ROS (H2DCFDA), mitochondrial dysfunction (TMRE), lipid droplets (Nile Red), and autophagic vacuoles (MDC) were assessed. Flow cytometry characterized cell cycle distribution and cell death. Caspase 3/7 activity and CASP3 expression confirmed apoptosis. Molecular docking and gene expression analysis validated TMBP-CDK1 interaction. TMBP reduced cell viability, with IC50 values of 68 and 55 µM (HuH7.5) and 50 and 42 µM (HepG2/C3A) at 24 and 48 h. TMBP induced severe morphological alterations, impaired migration, increased ROS, mitochondrial dysfunction, increased lipid droplets and autophagic vacuoles. TMBP also led to G2/M arrest and apoptosis, likely via CDK1 inhibition through hydrogen bonding at Tyr15. These findings highlight TMBP as a promising therapeutic candidate targeting CDK1 in HCC.